M

Magellan Health Inc
F:MAH1

Watchlist Manager
Magellan Health Inc
F:MAH1
Watchlist
Price: 83.5 EUR Market Closed
Market Cap: 2.2B EUR
Have any thoughts about
Magellan Health Inc?
Write Note
Section:
 

Relative Value

MAH1 price has not been updated for more than 1 year. This may indicate that the stock has been delisted.

There is not enough data to reliably calculate the relative value of MAH1.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MAH1 Relative Value
Base Case
Not Available
M
Worst Case
Base Case
Best Case

Valuation Multiples

0.5
P/S
P/S
Price to Sales
0.5
vs History
vs Industry
Median 3Y
0.5
Median 5Y
0.5
Industry
2.3
Forward
0.5
More Details
7.6
P/E
P/E
Price to Earnings
7.6
vs History
vs Industry
Median 3Y
13.9
Median 5Y
7.9
Industry
23.1
Forward
47.2
More Details
12.3
P/OCF
P/OCF
Price to OCF
12.3
vs History
vs Industry
Median 3Y
13.5
Median 5Y
13
Industry
14.2
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
10.8
Median 5Y
-76.6
Industry
20.1
More Details
1.2
P/B
P/B
Price to Book Value
1.2
vs History
vs Industry
Median 3Y
1.3
Median 5Y
1.2
Industry
2.2
More Details
0.3
EV/S
EV/S
Enterprise Value to Sales
0.3
vs History
vs Industry
Median 3Y
0.5
Median 5Y
0.4
Industry
2.4
Forward
0.3
More Details
11.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
11.4
vs History
vs Industry
Median 3Y
13.5
Median 5Y
12.1
Industry
5
More Details
11.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
11.1
vs History
vs Industry
Median 3Y
12.1
Median 5Y
11.7
Industry
12.7
More Details
33
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
33
vs History
vs Industry
Median 3Y
37.3
Median 5Y
34.7
Industry
17.1
More Details
8.8
EV/OCF
EV/OCF
Enterprise Value to OCF
8.8
vs History
vs Industry
Median 3Y
17.7
Median 5Y
9.5
Industry
14
More Details
13.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
13.9
vs History
vs Industry
Median 3Y
15.7
Median 5Y
14.6
Industry
18
More Details
0.9
EV/IC
EV/IC
Enterprise Value to IC
0.9
vs History
vs Industry
Median 3Y
0.9
Median 5Y
0.9
Industry
1.9
More Details

Multiples Across Competitors

MAH1 Competitors Multiples
Magellan Health Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Magellan Health Inc
F:MAH1
2.2B EUR 0.5 7.6 11.1 33
US
UnitedHealth Group Inc
NYSE:UNH
467.6B USD 1.2 32.7 13.9 15.7
US
Anthem Inc
LSE:0HG8
95.9B USD 0.6 14.9 10.6 12.3
US
Elevance Health Inc
NYSE:ELV
86B USD 0.5 13.4 9.7 11.2
US
Centene Corp
NYSE:CNC
30.7B USD 0.2 10 7.2 10.1
US
Humana Inc
NYSE:HUM
30.8B USD 0.3 22.7 8.5 10.9
US
Molina Healthcare Inc
NYSE:MOH
16.8B USD 0.4 14.7 5.5 6.1
US
Healthequity Inc
NASDAQ:HQY
8.3B USD 7.2 85.4 25 45.1
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
17.1B BRL 1 -40 7 15.8
US
Clover Health Investments Corp
NASDAQ:CLOV
1.6B USD 1.1 -17.8 -18.5 -18.1
US
Progyny Inc
NASDAQ:PGNY
1.3B USD 1.1 22.4 15.3 16
P/E Multiple
Earnings Growth P/E to Growth
US
M
Magellan Health Inc
F:MAH1
Average P/E: 24.8
7.6
N/A N/A
US
UnitedHealth Group Inc
NYSE:UNH
32.7
40%
0.8
US
A
Anthem Inc
LSE:0HG8
14.9
60%
0.2
US
Elevance Health Inc
NYSE:ELV
13.4
60%
0.2
US
Centene Corp
NYSE:CNC
10
51%
0.2
US
Humana Inc
NYSE:HUM
22.7
-31%
N/A
US
Molina Healthcare Inc
NYSE:MOH
14.7
56%
0.3
US
Healthequity Inc
NASDAQ:HQY
85.4
615%
0.1
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
Negative Multiple: -40 N/A N/A
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -17.8 N/A N/A
US
Progyny Inc
NASDAQ:PGNY
22.4
25%
0.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
M
Magellan Health Inc
F:MAH1
Average EV/EBITDA: 11.4
11.1
N/A N/A
US
UnitedHealth Group Inc
NYSE:UNH
13.9
32%
0.4
US
A
Anthem Inc
LSE:0HG8
10.6
20%
0.5
US
Elevance Health Inc
NYSE:ELV
9.7
20%
0.5
US
Centene Corp
NYSE:CNC
7.2
6%
1.2
US
Humana Inc
NYSE:HUM
8.5
-31%
N/A
US
Molina Healthcare Inc
NYSE:MOH
5.5
39%
0.1
US
Healthequity Inc
NASDAQ:HQY
25
136%
0.2
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
7
72%
0.1
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -18.5 N/A N/A
US
Progyny Inc
NASDAQ:PGNY
15.3
262%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
M
Magellan Health Inc
F:MAH1
Average EV/EBIT: 17.6
33
N/A N/A
US
UnitedHealth Group Inc
NYSE:UNH
15.7
36%
0.4
US
A
Anthem Inc
LSE:0HG8
12.3
31%
0.4
US
Elevance Health Inc
NYSE:ELV
11.2
31%
0.4
US
Centene Corp
NYSE:CNC
10.1
20%
0.5
US
Humana Inc
NYSE:HUM
10.9
-38%
N/A
US
Molina Healthcare Inc
NYSE:MOH
6.1
41%
0.1
US
Healthequity Inc
NASDAQ:HQY
45.1
174%
0.3
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
15.8
191%
0.1
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -18.1 N/A N/A
US
Progyny Inc
NASDAQ:PGNY
16
217%
0.1

See Also

Summary
MAH1 intrinsic value, competitors valuation, and company profile.
DCF Valuation
MAH1 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MAH1 stock valuation using valuation multiples.
Wall Street Estimates
MAH1 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MAH1 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.